Noticias de TEVA_US
Noticias del mercado
Últimas noticias sobre TEVA_US — 208 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Teva Pharmaceutical Industries Ltd (TEVA) Q1 2026 Earnings Call Highlights: Strong Innovative ... By GuruFocus
Teva Pharmaceutical se recuperó por tercer día consecutivo el miércoles, subiendo un 11,89 por ciento para cerrar a 35,38 dólares cada uno, mientras los inversores se animaban por el sólido desempeño de sus ganancias en el primer trimestre...
Teva Pharmaceutical Industries Ltd (TEVA) Shares Surge 11.9% -- What GF Score of 58 Tells Investors
Truist Financial Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $45
Teva Surges 12% — And It's Not Completely Tied To Earnings
With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
Teva Signals Confidence With $700M Pipeline Push, Buyback Plan - Teva Pharmaceutical Indus (NYSE:TEVA)
Teva Rises After Sales Top Estimates on Branded Shift
Teva Enjoys Strong Start to 2026 Thanks to Strong Momentum in Branded Portfolio
Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock
Teva Pharmaceutical (TEVA) Reports Strong Q1 Earnings, Beats Exp
Teva Pharmaceutical (TEVA) Reports Q1 Earnings Beat, Adjusts 202
Teva Pharmaceutical Indus Q1 2026 Earnings Call Transcript
Teva inks $700M Emalex buyout to bag near-approval Tourette drug
Teva Pharmaceutical (TEVA) Reports Strong Q1 Earnings, Beats Exp
Página 5 de 11
